SYT15 (Gene)

Organism:

Homo sapiens

Synonyms:CHR10SYT, ENTREZ:83849, HGNC:17167, MIM:608081, NM_031912, NM_181519, NP_114118, NP_852660, SYT15, XM_006718011, XM_017016750, XM_017016751, XM_017016752, XM_017016753, XM_024448228, XP_006718074, XP_016872239, XP_016872240, XP_016872241, XP_016872242, XP_024303996, XR_001747224, XR_428721, synaptotagmin 15, sytXV

Omim:OMIM:608081

Id:ENSG00000204176

Hgnc:HGNC:17167

Entrez:83849

Ensembl:ENSG00000204176

Description:synaptotagmin 15

This gene encodes a member of the Synaptotagmin (Syt) family of membrane trafficking proteins. Members of this family contain a transmembrane region and a C-terminal-type tandem C2 domain. Unlike related family members, the encoded protein may be involved in membrane trafficking in non-neuronal tissues. Two trancript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View SYT15's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with SYT15.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using SYT15.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for SYT15.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SYT15.

Results found

Linked to

	Label	Description
	GSE172016 2 V 0 PACLITAXEL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 2 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126463 pomalidomide MM1.S 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 4 V 3 CHLOROQUINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE126463 0 V 3 POMALIDOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 2 V 6 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE131649 4 V 8 HEMIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE103122 puromycin 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE103122 0 V 1 PUROMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE205332 1 V 0 QUEUINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE172016 2 V 0 PACLITAXEL HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 temozolomide LN-308 2 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE126463 pomalidomide MM1.S 0 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE159678 4 V 3 CHLOROQUINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE126463 0 V 3 POMALIDOMIDE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 2 V 6 TEMOZOLOMIDE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE131649 4 V 8 HEMIN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE103122 puromycin 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE103122 0 V 1 PUROMYCIN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE205332 1 V 0 QUEUINE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.